Ophthalmologist Sunir J. Garg, M.D., is serving on the editorial board for MerckManuals.com, an authoritative online medical reference.
Dr. Garg is Professor of Ophthalmology at the Retina Service of Wills Eye Hospital, Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia and a partner at MidAtlantic Retina.
Dr. Garg is a graduate of the medical school at University of Michigan where he also did his residency. He completed his retina fellowship at Wills Eye Hospital. Dr. Garg is a member of the American Society of Retina Specialists.
About the Merck Manuals
More than 350 medical experts currently serve as contributors to MerckManuals.com; content is reviewed by an independent editorial board and regularly updated online.
Visitors to www.MerckManuals.com can choose between advanced content designed for healthcare professionals and medical students, or easier to understand material tailored to patients and consumers.
Users of the website will find an ever expanding online collection of assets, including a news feed, commentary, infographics, videos, podcasts, 3D models, as well as health calculators and trackers.
Provided as a public service by Merck & Co., Inc., access to the website is unlimited and always free, there is no registration, and visitors are never asked to provide personal information. The user experience is not compromised by advertising or sponsored content of any kind.
The digital offering is the most up-to-date version of the subject matter contained in The Merck Manuals, a series of medical reference books long trusted by doctors and patients alike.
First published in 1899, The Merck Manual for professionals is now in its 20th edition. The first edition of the consumer version of the book was introduced in 1997.
Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.